• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源神经保护素通过识别 Aβ发挥神经保护作用的 FPR2 结构基础

Structural basis of FPR2 in recognition of Aβ and neuroprotection by humanin.

机构信息

CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.

School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China.

出版信息

Nat Commun. 2022 Apr 1;13(1):1775. doi: 10.1038/s41467-022-29361-x.

DOI:10.1038/s41467-022-29361-x
PMID:35365641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8976073/
Abstract

Formyl peptide receptor 2 (FPR2) has been shown to mediate the cytotoxic effects of the β amyloid peptide Aβ and serves as a receptor for humanin, a peptide that protects neuronal cells from damage by Aβ, implying its involvement in the pathogenesis of Alzheimer's disease (AD). However, the interaction pattern between FPR2 and Aβ or humanin remains unknown. Here we report the structures of FPR2 bound to G and Aβ or N-formyl humanin (fHN). Combined with functional data, the structures reveal two critical regions that govern recognition and activity of Aβ and fHN, including a polar binding cavity within the receptor helical bundle and a hydrophobic binding groove in the extracellular region. In addition, the structures of FPR2 and FPR1 in complex with different formyl peptides were determined, providing insights into ligand recognition and selectivity of the FPR family. These findings uncover key factors that define the functionality of FPR2 in AD and other inflammatory diseases and would enable drug development.

摘要

甲酰肽受体 2(FPR2)已被证明介导β淀粉样肽 Aβ 的细胞毒性作用,并作为人源神经保护素(HN)的受体,HN 是一种能保护神经元细胞免受 Aβ 损伤的肽,这意味着它参与了阿尔茨海默病(AD)的发病机制。然而,FPR2 与 Aβ 或人源神经保护素(HN)之间的相互作用模式仍不清楚。在这里,我们报告了 FPR2 与 G 和 Aβ 或 N-甲酰基人源神经保护素(fHN)结合的结构。结合功能数据,这些结构揭示了两个关键区域,它们控制着 Aβ 和 fHN 的识别和活性,包括受体螺旋束内的极性结合腔和细胞外区域的疏水性结合槽。此外,还确定了 FPR2 和 FPR1 与不同甲酰肽复合物的结构,为 FPR 家族的配体识别和选择性提供了深入了解。这些发现揭示了定义 FPR2 在 AD 和其他炎症性疾病中的功能的关键因素,并将能够促进药物开发。

相似文献

1
Structural basis of FPR2 in recognition of Aβ and neuroprotection by humanin.人源神经保护素通过识别 Aβ发挥神经保护作用的 FPR2 结构基础
Nat Commun. 2022 Apr 1;13(1):1775. doi: 10.1038/s41467-022-29361-x.
2
Structural basis of ligand binding modes at the human formyl peptide receptor 2.人源甲酰肽受体 2 配体结合模式的结构基础。
Nat Commun. 2020 Mar 5;11(1):1208. doi: 10.1038/s41467-020-15009-1.
3
Mitocryptide-2: Identification of Its Minimum Structure for Specific Activation of FPR2-Possible Receptor Switching from FPR2 to FPR1 by Its Physiological C-terminal Cleavages.Mitocryptide-2:其特定激活 FPR2 的最小结构的鉴定-通过其生理 C 末端切割可能从 FPR2 到 FPR1 的受体转换。
Int J Mol Sci. 2021 Apr 15;22(8):4084. doi: 10.3390/ijms22084084.
4
Structural determinants for the interaction of formyl peptide receptor 2 with peptide ligands.结构决定因素对甲酰肽受体 2 与肽配体的相互作用。
J Biol Chem. 2014 Jan 24;289(4):2295-306. doi: 10.1074/jbc.M113.509216. Epub 2013 Nov 27.
5
Structural Determinants in the -Derived Phenol-Soluble Modulin α2 Peptide Required for Neutrophil Formyl Peptide Receptor Activation.- 衍生的酚溶性髓样蛋白 α2 肽中用于中性粒细胞_FORMYLPEPTIDE_RECEPTOR 激活的结构决定因素。
J Immunol. 2022 Apr 1;208(7):1632-1641. doi: 10.4049/jimmunol.2101039. Epub 2022 Mar 23.
6
Structural characterization and inhibitory profile of formyl peptide receptor 2 selective peptides descending from a PIP2-binding domain of gelsolin.从凝胶蛋白的 PIP2 结合结构域衍生的具有降钙素基因相关肽受体 2 选择性的结构特征和抑制谱的肽。
J Immunol. 2012 Jul 15;189(2):629-37. doi: 10.4049/jimmunol.1101616. Epub 2012 Jun 15.
7
Non-peptide ligand binding to the formyl peptide receptor FPR2--A comparison to peptide ligand binding modes.非肽配体与甲酰肽受体FPR2的结合——与肽配体结合模式的比较
Bioorg Med Chem. 2015 Jul 15;23(14):4072-81. doi: 10.1016/j.bmc.2015.03.062. Epub 2015 Mar 28.
8
Biased allosteric modulation of formyl peptide receptor 2 leads to distinct receptor conformational states for pro- and anti-inflammatory signaling.变构调节甲酰肽受体 2 会导致促炎和抗炎信号的受体构象状态不同。
Pharmacol Res. 2020 Nov;161:105117. doi: 10.1016/j.phrs.2020.105117. Epub 2020 Aug 5.
9
Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor.人胰岛素(Humanin)是一种新发现的神经保护因子,它将G蛋白偶联的类甲酰肽受体-1用作功能受体。
J Immunol. 2004 Jun 1;172(11):7078-85. doi: 10.4049/jimmunol.172.11.7078.
10
Peptide length and folding state govern the capacity of staphylococcal β-type phenol-soluble modulins to activate human formyl-peptide receptors 1 or 2.短肽长度和折叠状态决定葡萄球菌β型酚可溶性调节素激活人源甲酰肽受体 1 或 2 的能力。
J Leukoc Biol. 2015 Apr;97(4):689-97. doi: 10.1189/jlb.2A0514-275R. Epub 2015 Feb 27.

引用本文的文献

1
Monoclonal Antibody 5F1 Modulates Formyl Peptide Receptor 1 Conformation for Transmembrane Signaling.单克隆抗体5F1调节趋化因子受体1的构象以进行跨膜信号传导。
FASEB Bioadv. 2025 Sep 8;7(9):e70037. doi: 10.1096/fba.2025-00145. eCollection 2025 Sep.
2
Bioactive Compounds as Modulators of N-Formyl Peptide Signaling in Chronic Diseases.生物活性化合物作为慢性疾病中N-甲酰肽信号传导的调节剂
Molecules. 2025 Jul 16;30(14):2981. doi: 10.3390/molecules30142981.
3
ALX/FPR2 Receptor Activation by Inflammatory (fMLFII) and Pro-resolving (LXA and RvD3) Agonists.

本文引用的文献

1
Aβ(1-42) tetramer and octamer structures reveal edge conductivity pores as a mechanism for membrane damage.Aβ(1-42)四聚体和八聚体结构揭示边缘传导孔作为膜损伤的机制。
Nat Commun. 2020 Jun 15;11(1):3014. doi: 10.1038/s41467-020-16566-1.
2
Structural basis of ligand binding modes at the human formyl peptide receptor 2.人源甲酰肽受体 2 配体结合模式的结构基础。
Nat Commun. 2020 Mar 5;11(1):1208. doi: 10.1038/s41467-020-15009-1.
3
Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer's brain tissue.
炎症(fMLFII)和促消退(LXA和RvD3)激动剂对ALX/FPR2受体的激活作用
ACS Phys Chem Au. 2025 Jun 6;5(4):367-374. doi: 10.1021/acsphyschemau.5c00008. eCollection 2025 Jul 23.
4
Chemosensory Receptors in Vertebrates: Structure and Computational Modeling Insights.脊椎动物的化学感受器:结构与计算建模见解
Int J Mol Sci. 2025 Jul 10;26(14):6605. doi: 10.3390/ijms26146605.
5
DAMPs cross-talk interpretation of MDD mechanisms.损伤相关分子模式对重度抑郁症机制的相互作用解读
Sci Adv. 2025 Jul 25;11(30):eadx3698. doi: 10.1126/sciadv.adx3698.
6
The -formyl peptide receptors: much more than chemoattractant receptors. Relevance in health and disease.甲酰肽受体:远不止是趋化因子受体。在健康与疾病中的意义。
Front Immunol. 2025 Mar 4;16:1568629. doi: 10.3389/fimmu.2025.1568629. eCollection 2025.
7
Formyl peptide receptor 2: a potential therapeutic target for inflammation-related diseases.甲酰肽受体2:炎症相关疾病的潜在治疗靶点。
Pharmacol Rep. 2025 Jun;77(3):593-609. doi: 10.1007/s43440-025-00704-x. Epub 2025 Mar 18.
8
Role of FPR2 antagonism in alleviating social isolation-induced depression and protecting blood-brain barrier integrity.FPR2拮抗剂在减轻社会隔离诱导的抑郁和保护血脑屏障完整性中的作用。
J Neuroinflammation. 2025 Mar 13;22(1):79. doi: 10.1186/s12974-025-03408-4.
9
Oral FPR2/ALX modulators tune myeloid cell activity to ameliorate mucosal inflammation in inflammatory bowel disease.口服FPR2/ALX调节剂可调节髓样细胞活性,以改善炎症性肠病中的黏膜炎症。
Acta Pharmacol Sin. 2025 Mar 11. doi: 10.1038/s41401-025-01525-7.
10
Structure of G protein-coupled receptor GPR1 bound to full-length chemerin adipokine reveals a chemokine-like reverse binding mode.G 蛋白偶联受体 GPR1 与全长趋化素脂肪因子结合的结构揭示了一种类似趋化因子的反向结合模式。
PLoS Biol. 2024 Oct 28;22(10):e3002838. doi: 10.1371/journal.pbio.3002838. eCollection 2024 Oct.
从阿尔茨海默病脑组织中纯化的 Aβ 淀粉样纤维的冷冻电镜结构和多态性。
Nat Commun. 2019 Oct 29;10(1):4760. doi: 10.1038/s41467-019-12683-8.
4
New tools for automated high-resolution cryo-EM structure determination in RELION-3.用于 RELION-3 中自动化高分辨率冷冻电镜结构测定的新工具。
Elife. 2018 Nov 9;7:e42166. doi: 10.7554/eLife.42166.
5
Orthosteric and allosteric action of the C5a receptor antagonists.C5a 受体拮抗剂的变构和变构作用。
Nat Struct Mol Biol. 2018 Jun;25(6):472-481. doi: 10.1038/s41594-018-0067-z. Epub 2018 Jun 4.
6
MolProbity: More and better reference data for improved all-atom structure validation.MolProbity:用于改进全原子结构验证的更多更好的参考数据。
Protein Sci. 2018 Jan;27(1):293-315. doi: 10.1002/pro.3330. Epub 2017 Nov 27.
7
Fibril structure of amyloid-β(1-42) by cryo-electron microscopy.通过冷冻电子显微镜观察β-淀粉样蛋白(1-42)的原纤维结构
Science. 2017 Oct 6;358(6359):116-119. doi: 10.1126/science.aao2825. Epub 2017 Sep 7.
8
Amyloid beta: structure, biology and structure-based therapeutic development.淀粉样β:结构、生物学和基于结构的治疗开发。
Acta Pharmacol Sin. 2017 Sep;38(9):1205-1235. doi: 10.1038/aps.2017.28. Epub 2017 Jul 17.
9
The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition.甲酰肽受体:配体的多样性与识别机制
Molecules. 2017 Mar 13;22(3):455. doi: 10.3390/molecules22030455.
10
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy.MotionCor2:用于改进冷冻电子显微镜的束流诱导运动的各向异性校正
Nat Methods. 2017 Apr;14(4):331-332. doi: 10.1038/nmeth.4193. Epub 2017 Feb 27.